Errors in Abstract and Figure 2
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiverse Scientific and Economic Studies · Meta-analysis and systematic reviews · Pharmacy and Medical Practices
In the Original Investigation titled “Epidemiology of Neuroendocrine Neoplasms in the US,”^1^ published June 24, 2025, the estimated 20-year limited duration prevalence of neuroendocrine neoplasms in the US on January 1, 2021, should have been reported as 248 546 cases instead of 243 896. In addition, the decimal placement in the y-axes of Figure 2 was incorrect. This article has been corrected.^1^
The reference list from the paper itself. Each links out to its DOI / PubMed record.